🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

(MAMMA): Make America Manufacture Medicines Again Y Combinator

We condemn Russia’s unprovoked aggression against #Ukraine as we mark 1000 days of the war today. 1000 long days of killing, devastation, suffering and broken dreams. But also 1000 bold days of bravery, patriotism, sacrifice and fighting for principles that we jointly believe in

Great joining "Our mRNA Future" panel @Alliance for #mRNA Medicines' #AMM2024 with colleagues from Replicate, Sanofi, NEB, ThermoFisher, Cytiva. We discussed mRNA democratization, personalized mRNA therapies & "3rd gen" mRNA medicines. We're working on all of 'em Sensible Biotechnologies!

Lord Hague of Richmond will serve as the next Chancellor of University of Oxford, having won a majority of support in the final round of voting for the post. Lord Hague becomes the 160th recorded Chancellor in the University’s history, a role that dates back at least 800 years.

I am very excited that Sensible Biotechnologies is among Deloitte Impact Stars featured in CE Fast 50 Report! It is a great recognition of our work on building 1st cell-based mRNA platform to design and optimize next generation of #mRNA medicines and to advance global biosecurity.

New paper with novel biological quantum effects measured for the first time - and developed for applications in Synthetic Biology!

Convinced that AI for antibody design is starting to work & this will meaningfully shrink timeline to DC. Overlooked potential consequence is that this could increase IRR for preclinical bets at the point of target and bring in more capital into early-stage biotech

Thrilled to announce that Sensible Biotechnologies was accepted into NATO Defence Innovation Accelerator for the North Atlantic. Excited to build 1st cell-based platform for mRNA design & manufacturing to enable next-gen of #mRNA medicines & strengthen global biosecurity with NATO’s help.

Honored to be nominated for the Crystal Wing Award (Kristalove Kridlo) in Innovations & Startups! Grateful for this recognition of Sensible Biotechnologies work in #mRNA space & growth of Slovak bioeconomy. Congrats to all the nominees! Learn more: kristalovekridlo.sk/nominovani-202…

Thrilled to contribute to The mRNA Multiplier, Tony Blair Institute for Global Change's vision for UK #mRNA leadership, from novel medicines to better biosecurity. We think Sensible Biotechnologies's cell-based platform will be one of the field's core enabling innovations. Read more: institute.global/insights/publi…

Dusting off my accordion for the Christmas holidays with “Čas radosti, veselosti” – a Slovak carol from 1505. Music brings us together; may it add joy to your Christmas filled with love, peace & happiness. #Christmas

Proud of all the progress Sensible Biotechnologies made in 2024—advancing our cell-based mRNA platform, building partnerships, and growing our team. Excited for 2025 and the breakthroughs ahead in mRNA innovation! #mRNAMadeBetter #SensibleBio #biosecurity #biomanufacturing

Excited to discuss #biomanufacturing's transformative potential for Slovakia’s economy and Sensible Biotechnologies's work in #mRNA innovation with Miro Wlachovsky. We are super optimistic for 2025 Full interview in Slovak is on this link: sita.sk/okno-do-sveta-…

Excited to be at #JPM2025 in SF with my Co-Founder Marian Kupculak talking about Sensible Biotechnologies! 🌞 Catch us presenting at the Alliance for mRNA Medicines breakfast on Jan 15. Also, let's talk about our cell-based #mRNA platform and building better mRNA medicines together.

Amen Vishal Gulati (I back scientists)

BIG DAY for personalized stem cell-derived replacements!! We are proud to collaborate with the Gene and Cell Therapy Institute at MGB! 💜💜💜🙏🏼🙏🏼🙏🏼🚀🚀🚀

Excited to host a roundtable on mRNA therapeutics at #RNALeaders 2025 in Basel! Join my Co-Founder Marian Kupculak and me to learn more about our work Sensible Biotechnologies on building the first-in-class platform for design and production of high-quality #mRNA